To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
OncLive
Hadeel Assad, M.D., medical oncologist and member of the Breast Cancer and Phase I Clinical-Pharmacology Multidisciplinary Teams (MDTs) at Barbara Ann Karmanos Cancer Institute, chaired an educational discussion for one of OncLive's Institutional Perspectives in Cancer virtual events, part of the State of the Science Summits. Dr. Assad was joined by Breast Cancer MDT members and medical oncologists Lawrence Flaherty, M.D., Jailan Elayoubi, M.D., and Michael Simon, M.D., MPH, co-leader of the Breast Cancer MDT, to cover topics such as early stage and metastatic HER2+, CDK 4/6 inhibitors, triple-negative breast cancer and emerging new agents.
View the full virtual event here. (You will be prompted to register before viewing the recorded event.)